Cargando…

Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes

OBJECTIVE: We aimed to investigate the factors associated with UTI in patients with T2D whether being treated with SGLT-2i or not. METHODS: Adult patients with T2D, whose urine culture results were available, were analyzed retrospectively. Urine culture was obtained from mid-flow urine. Antibacteria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanrıverdi, Mustafa, Baştemir, Mehmet, Demirbakan, Hadiye, Ünalan, Alperen, Türkmen, Merve, Tanrıverdi, Gülşen Özkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548559/ https://www.ncbi.nlm.nih.gov/pubmed/37789335 http://dx.doi.org/10.1186/s12902-023-01464-6

Ejemplares similares

New Method Improves the Evaluation of Subclinical Left Ventricular Dysfunction in Type 2 Diabetes Mellitus
por: Askin, Lutfu, et al.
Publicado: (2019)

Copeptin levels in patients with coronary artery ectasia
por: Yavcin, Ozkan, et al.
Publicado: (2019)

Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
por: Hazique, Mohammad, et al.
Publicado: (2023)

Clinical importance of high- sensitivity troponin T in patients without coronary artery disease
por: Askin, Lutfu, et al.
Publicado: (2020)

The relationship between coronary artery disease and depression and anxiety scores
por: Askin, Lutfu, et al.
Publicado: (2020)

The relationship between coronary artery disease and SIRT1 protein
por: Askin, Lutfu, et al.
Publicado: (2020)

A Associação da Relação Proteína C-Reativa/Albumina em Pacientes com Ectasia da Artéria Coronária Isolada
por: Sercelik, Alper, et al.
Publicado: (2020)

The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers
por: Demir, Mehmet Emin, et al.
Publicado: (2023)

The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study
por: Uitrakul, Suriyon, et al.
Publicado: (2022)

Determination of Cystic Fibrosis Mutation Frequency in Preterm and Term Neonates with Respiratory Tract Problems
por: Tanriverdi, S, et al.
Publicado: (2022)

SGLT-2 inhibitors and their potential in the treatment of diabetes
por: Rosenwasser, Rebecca F, et al.
Publicado: (2013)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
por: Tanriverdi, Ozgur
Publicado: (2020)

Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research
por: Askin, Lutfu, et al.
Publicado: (2020)

Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia
por: Durcan, Emre, et al.
Publicado: (2022)

Risk of genital and urinary tract infections associated with SGLT‐2 inhibitors as an add‐on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea
por: Yang, Hyeri, et al.
Publicado: (2022)

SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
por: Saisho, Yoshifumi
Publicado: (2020)

SGLT2 inhibitors and the changing landscape for treatment of diabetes
por: Liu, Shuangbo, et al.
Publicado: (2019)

The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy
por: Sha, Wenjun, et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors
por: Chow, Erica, et al.
Publicado: (2023)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Neuroprotective Effect of SGLT2 Inhibitors
por: Pawlos, Agnieszka, et al.
Publicado: (2021)

Benefits of SGLT2 inhibitors in arrhythmias
por: Gao, Jinghan, et al.
Publicado: (2022)

The relationship between myocardial bridge and frontal QRS‐T angle
por: Tascanov, Mustafa Begenc, et al.
Publicado: (2022)

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction
por: Özkan, Uğur, et al.
Publicado: (2023)

Partial load-bearing rabbit ulnar segmental defects are regenerated with biocompatible grafts with or without bone marrow-derived mesenchymal stem cells
por: Basaran, Serdar Hakan, et al.
Publicado: (2022)

Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
por: Oranje, Paul, et al.
Publicado: (2019)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Potential Prognostic Role of Immune System Activation Marker Neopterin in Patients with Type 2 Diabetes
por: Ünüvar, Songül, et al.
Publicado: (2018)

Expressions of Endocan in Patients with Meningiomas and Gliomas
por: Atukeren, Pinar, et al.
Publicado: (2016)

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2022)

The floating first metacarpal: A rare case
por: Tanrıverdi, Bülent, et al.
Publicado: (2023)

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
por: Nauck, Michael A
Publicado: (2014)

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
por: Gomez-Peralta, Fernando, et al.
Publicado: (2017)

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
por: Kawanami, Daiji, et al.
Publicado: (2017)

SGLT2 inhibitors and renal complications in type 1 diabetes
por: Petrie, John R
Publicado: (2020)

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
por: Evans, Marc, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
por: Alhemeiri, Mohamed, et al.
Publicado: (2022)

The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021)

Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor
por: Ren, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ol41cta0sm8kfdomptbm12cj8d